This content is machine translated Therapy-refractory focal epilepsy New add-on antiepileptic drug significantly reduces seizure frequency For the treatment of focal epilepsy that cannot be adequately controlled despite previous therapy with at least two anticonvulsants, a new add-on therapy has recently become available for adults –…
View Post 3 min This content is machine translated Brain diseases Supply strategies discussed on an interdisciplinary basis Representatives from neurology, psychiatry and pharmacy met for the first time at the Berlin Brain Summit for an interdisciplinary summit on brain diseases. The aim of the inter-professional exchange was…
View Post 2 min This content is machine translated Mad Pride Mental health support On June 18, 2022, the Mad Pride took place in Bern. The aim was to raise awareness of the topic of “mental illness” and to break down prejudices. The federal government…
View Post 7 min This content is machine translated Headache Arriving at the diagnosis with “Red Flags Headache is the second most common cause of pain worldwide [1]. Three billion people are affected every year and often the diagnosis of the different types of headaches causes headaches…
View Post 5 min This content is machine translated Parkinson's therapy Studies on α-synuclein-binding antibodies disappointed Parkinson’s disease is a chronically progressive, neurodegenerative disease that, if left untreated, can quickly lead to a severely diminished quality of life due to its motor symptoms. Currently, there are…
View Post 4 min This content is machine translated No stent for stroke and intracranial stenosis? New data does not justify general exclusion TIA and stroke patients with advanced intracranial stenoses should generally not be stented – according to a 2016 G-BA decision. A recent randomized trial [1] shows: clinically stable patients do…
View Post 2 min This content is machine translated Neuroregeneration in multiple sclerosis Involved cells and supporting drug identified Regeneration in the CNS is a rare event and is strongly limited to the replacement of so-called oligodendroglial cells and their electrically insulating elements of the axons, called myelin sheaths.…
View Post 5 min This content is machine translated Pain Management Living at last – on the track of the individually best therapy Improving care in pain and palliative situations was the focus of this year’s Pain Congress. Patients with chronic pain in particular require individualized treatment in order to finally be able…
View Post 6 min This content is machine translated Head and neck tumors New prognostic models and biomarkers in focus of development Malignant tumors in the head and/or neck area always pose challenges for experts. Immunotherapy can now be used to treat a wide range of cancers, but the response rate often…
View Post 4 min This content is machine translated Multiple sclerosis The role of astrocytes in progress management. In chronic neurodegenerative diseases such as multiple sclerosis, CNS cells make various adaptations during neuroinflammation. The main cells involved in this inflammatory process are the glial cells, among which the…
View Post 3 min This content is machine translated NMOSD Current figures speak for early therapy management Rare autoimmune diseases such as neuromyelitis optica spectrum disease (NMOSD) and myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) are united by ignorance of quality of life and socioeconomic costs of illness.…
